- Filed
- Aug 29, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Aug 28, 2024 | 23.8M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 7.69M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 12.06K sh |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | −$690.27K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$539K |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | −$102.5K |
| Stockholders Equity restated | Q1 2024 · Dec 31, 2023 | $1.25M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $14.75M |
| Current Liabilities restated | Q1 2024 · Dec 31, 2023 | $14.98M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $16.04M |
| Total Liabilities restated | Q1 2024 · Dec 31, 2023 | $16.37M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $5.02M |
| Current Assets restated | Q1 2024 · Dec 31, 2023 | $5.38M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $16.67M |
| Total Assets restated | Q1 2024 · Dec 31, 2023 | $17.25M |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | −$0.37 |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | −$719.12 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | −$0.37 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | −$719.12 |
| Sga Expense | Q1 2024 · Mar 31, 2024 | $4.2M |
| Sga Expense restated | Q1 2024 · Mar 31, 2023 | $9.97M |
| Net Income | Q1 2024 · Mar 31, 2024 | −$2.86M |
| Net Income restated | Q1 2024 · Mar 31, 2023 | −$8.67M |
| Operating Income | Q1 2024 · Mar 31, 2024 | −$2.35M |
| Operating Income restated | Q1 2024 · Mar 31, 2023 | −$8.31M |
| Gross Profit | Q1 2024 · Mar 31, 2024 | $1.85M |
| Gross Profit | Q1 2024 · Mar 31, 2023 | $1.65M |
| Cost Of Revenue | Q1 2024 · Mar 31, 2024 | $2.28M |
| Cost Of Revenue | Q1 2024 · Mar 31, 2023 | $4.07M |
| Revenue | Q1 2024 · Mar 31, 2024 | $4.14M |
| Revenue | Q1 2024 · Mar 31, 2023 | $5.72M |